Twin Focus Capital Partners, LLC Novartis Ag Transaction History

Twin Focus Capital Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $50,053 - $56,756	-541 Reduced 20.41%	2,110 $212,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $13,044 - $15,128	-163 Reduced 5.79%	2,651 $243,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $5,288 - $6,476	70 Added 2.55%	2,814 $255,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $5,222 - $6,108	-70 Reduced 2.49%	2,744 $209,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $1,529 - $1,781	19 Added 0.68%	2,814 $238,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $10,334 - $11,689	129 Added 4.84%	2,795 $245,000
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $21,310 - $23,537	250 Added 10.35%	2,666 $243,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $142,451 - $167,989	-1,706 Reduced 41.39%	2,416 $207,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $321,804 - $389,240	4,122 New	4,122 $389,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $260,548 - $288,652	-3,172 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $224,165 - $314,059	3,172 New	3,172 $262,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.